Jiuzhoutong Pharmaceutical Group Co., Ltd. is a large enterprise group with wholesale, retail chains, pharmaceutical production and R&D and related value-added services as its core business.

As of December 31, 2012, Jiuzhoutong Pharmaceutical Group has total assets of 14.804 billion yuan, 9,148 employees, more than 80 subsidiaries, and 875 retail chain pharmacies directly and franchise. In 2012, Jiuzhoutong Pharmaceutical Group achieved operating income of 29.508 billion yuan and paid nearly 500 million yuan in taxes.

Jiuzhoutong Pharmaceutical Group has a complete variety structure and rich customer resources, with more than 160,000 business specifications, 5,600 upstream suppliers and more than 70,000 downstream customers, and has obtained national or regional general distribution or general agent qualifications for 131 domestic drugs. So far, Jiuzhoutong Pharmaceutical Group has established 22 provincial subsidiaries (large pharmaceutical flow centers) in 22 provincial capital cities across the country, 29 prefecture-level companies (regional pharmaceutical flow distribution centers) and more than 400 terminal distribution points in 29 prefecture-level cities, forming a logistics distribution network covering most county-level administrative regions across the country.

To build the core competitiveness of the enterprise, Jiuzhoutong Pharmaceutical Group adheres to the concept of "technology makes service more outstanding" and is committed to the development and application of modern logistics technology and information technology. At present, Jiuzhoutong Pharmaceutical Group is the only pharmaceutical distribution company in China that has independent integrated logistics planning, logistics implementation, and system integration capabilities. It has obtained more than 20 independent intellectual property rights and is in a leading and internationally first-class position in modern logistics technology and information technology. It is the only company in the domestic pharmaceutical industry that has won the title of "China's 30 Years of Flag Enterprise for Logistics Reform and Opening Up in 30 Years".

Jiuzhoutong Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and has gradually extended technology value-added services to the upstream and downstream industrial chains, forming three unique product lines: logistics management, supply chain management, and hospital management, which can meet customers' highest technology requirements.

In recent years, Jiuzhoutong Pharmaceutical Group has won many honors such as "National 5A-level Logistics Enterprise", "Hubei Province's Most Influential Private Enterprise", "Hubei Province's Contract-abiding and Credit-oriented Enterprise", "China's Excellent Enterprise for Social Responsibility", and "National Non-public Enterprises' Double Strong Top 100 Party Organizations".

In the future, Jiuzhoutong Pharmaceutical Group will adapt to the changes in the pharmaceutical market, continue to adhere to the core business of pharmaceutical distribution, hospital pure sales, traditional Chinese medicinal materials, medical devices, retail chains as strategic businesses, and logistics technology marketing, e-commerce, international trade, raw materials, etc. as the business portfolio strategy; expand and improve the layout of the pharmaceutical marketing network, continuously provide cost-effective services for the pharmaceutical and health industry, and strive to build Jiuzhoutong into the best service provider of China's pharmaceutical and health industry.